Jeffrey Cadeddu, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    Transenterix
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    Titan Medical, Inc
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    Levita Magnetics
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Monarch Bioimplants
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Onconano
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    Transenterix
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    Titan Medical, Inc
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    Levita Magnetics
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Monarch Bioimplants
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Onconano

Pages

Return to Update Series (2020) Lesson 38: Ablative Therapies for Renal Masses: Current Treatment Indications, Types and Outcomes